Performance Disclosure - Jishi Media reported a net loss of 232 million yuan in the first half of 2025, with operating revenue of 999.7 million yuan, an increase of 8.7% year-on-year, compared to a net loss of 195 million yuan in the same period last year [1] - Sinopec's operating revenue for the first half of 2025 was 1.41 trillion yuan, a decrease of 10.6% year-on-year, with a net profit attributable to shareholders of 21.483 billion yuan, down 39.8% year-on-year [2] - Baofeng Energy achieved operating revenue of 22.82 billion yuan in the first half of 2025, an increase of 35.05% year-on-year, with a net profit attributable to shareholders of 5.718 billion yuan, up 73.02% year-on-year [3] Shareholding Changes - Zhongyin Securities announced that Jiangxi Copper intends to reduce its stake by no more than 8.334 million shares, representing up to 3% of the company's total share capital [4] - Boji Pharmaceutical's controlling shareholder Wang Tingchun and his concerted parties plan to reduce their holdings by no more than 1.14865 million shares, also up to 3% of the company's total share capital, between September 12, 2025, and December 11, 2025 [5] - Green Island Wind's shareholder, Zhenzhong Investment, intends to reduce its stake by no more than 680,000 shares, which is up to 1% of the company's total share capital [6] Risk Matters - Dameng Data announced that its director and senior vice president Chen Wen is under investigation, but the company's daily operations remain normal and business is progressing steadily [7]

此次减持是中银证券2020年上市以来，江铜股份的第二次减持。首次减持计划始于2022年4月，彼时江铜股份及其一致行动人江铜财务因自身经营发展需 要， 计划合计减持不超过中银证券总股本的4%，但最终的实际减持比例仅占总股本的0.99%。不过，这0.99%的股份皆系通过集中竞价方式减持。 8月21日晚间，中银证券发布公告称，公司股东江西铜业股份有限公司（以下简称"江铜股份"）因自身经营发展需要，计划在未来3个月内，通过集中竞价方 式及/或大宗交易方式合计减持公司股份，占比不超过公司总股本的3%。 截至今年一季度末，江铜股份为中银证券第三大股东。公开信息显示，中银证券重要股东上一轮减持高峰发生在2021年~2023年，部分股东已实现清仓式减 持。 江铜股份拟减持不超3%公司股份 今日晚间，中银证券发布公告称，公司股东江铜股份因自身经营发展需要，计划自公告之日起3个交易日后的3个月内通过集中竞价方式及/或大宗交易方式 合计减持公司股份不超过0.833亿股，不超过公司总股本的3%。其中通过集中竞价交易方式减持不超过0.278亿股，即不超过公司总股本的1%；通过大宗交 易方式减持不超过0.556亿股，即不超过公司总股本的 ...

据统计，8月21日，盘后银座股份披露增持情况。包括国脉科技、真视通、吉比特、鸿特科技、同飞股 份、绿岛风、博济医药、探路者、恒邦股份、中银证券在内的10家A股上市公司披露减持情况。 | | | 8.21上市公司盘后增持情况 | | --- | --- | --- | | 1 | 银座股份 | 控股股东拟增持1%-2%公司股份 | | | | 8.21上市公司盘后减持情况 | | 1 | 国脉科技 | 拟出售已回购的1.54%公司股份 | | 2 | 賣视通 | 股东计划减持不超过3%公司股份 | | 3 | 吉比特 | 副董事长陈拓琳拟减持不超过0.3470%公司股份 | | র | 鸡精科技 | 股东吴晓敏计划减持不超过1%的公司股份 | | 5 | 同飞股份 | 股东众和盈计划减持不超过764400股股份 | | 6 | 博济医药 | 控股股东干迁春及其一致行动人拟减持不超过3.00%公司股 | | 7 | 绿岛风 | 股东振中投资计划减持不超过1.00%公司股份 | | 8 | 探路者 | 大股东干静计划减持不超过0.5%公司股份 | | 0 | 中银证券 | 江西铜业拟减持公司不超3%股份 | | 1 ...

Group 1 - Shandong Commercial Group Co., Ltd., the controlling shareholder of Yinzuo Co., plans to increase its stake in the company by 1%-2% [1] - Hengbang Co. intends to reduce its holdings in Wanguo Gold by no more than 3.69% of its total share capital [1] - The controlling shareholder's concerted action partner of Zhen Shitong, Suzhou Longyue, plans to reduce its stake by no more than 3% [1] Group 2 - Jiang Copper Co., a shareholder of Zhongyin Securities, plans to reduce its stake by no more than 3% [1] - The controlling shareholder and its concerted action partners of Boji Pharmaceutical plan to reduce their holdings by no more than 3% [1] - Zhizhong Investment, a shareholder of Green Island Wind, plans to reduce its stake by no more than 1% [1] Group 3 - Wu Xiaomin, a shareholder of Hongte Technology, plans to reduce his stake by no more than 1% [1] - Wang Jing, the major shareholder of Tanjia, plans to reduce his stake by no more than 0.5% [1] - Zhonghe Ying, a shareholder of Tongfei Co., plans to reduce its stake by no more than 0.4503% [1] Group 4 - Chen Tuolin, the vice chairman of Jibite, plans to reduce his stake by no more than 0.3470% [1]

Buyback and Shareholder Actions - Sinopec plans to repurchase A-shares with a total fund of no less than RMB 5 billion and no more than RMB 10 billion, potentially reducing its registered capital [1] - Hengbang Mining intends to reduce its stake in the Hong Kong-listed company, WanGuo Gold, by up to 40 million shares, representing approximately 3.69% of WanGuo's total share capital [5] Product Approvals and Market Launches - Wantai Biological's nine-valent HPV vaccine has received the batch release certificate, marking its official market launch and enhancing the company's product lineup [1] - Changchun High-tech's subsidiary has received acceptance for the clinical trial application of GenSci143, a dual-specific antibody drug, which may provide new treatment options for certain tumors [7] Financial Performance - Hongxin Electronics reported a 15.01% increase in revenue to RMB 3.494 billion and a 9.85% rise in net profit to RMB 53.99 million for the first half of 2025 [2] - Sanwei Xinan experienced a net loss of RMB 29.39 million in the first half of 2025, despite a 15.19% increase in revenue to RMB 195 million [3] Corporate Developments - TianTan Bio received a commitment from its controlling shareholder to resolve new competition issues arising from a recent acquisition [4] - Feilu Co. announced a potential change in control, leading to a temporary suspension of its stock trading [8] Investment and Expansion - Jinbei Electric's subsidiary has signed a purchase agreement for a factory in Europe, marking significant progress in establishing its European production base [1] - Shengshi Technology plans to establish a wholly-owned subsidiary to integrate AI and humanoid robot technology with innovative toy products, investing RMB 10 million [6]

业绩披露 每经记者｜陈晴 每经编辑｜文多 博济医药：控股股东及其一致行动人拟减持不超公司3%的股份 博济医药公告，控股股东王廷春及一致行动人拟于2025年9月12日至2025年12月11日，通过大宗交易或 集中竞价合计减持不超过1148.65万股公司股份，即不超过公司总股本的3.00%。 吉视传媒：上半年净亏损2.32亿元 吉视传媒公告，2025年上半年营业收入为9.97亿元，同比增长8.70%，归母净利润为亏损2.32亿元，上 年同期公司净亏损1.95亿元。 中国石化：上半年归母净利润为214.83亿元 中国石化公告，2025年上半年营业收入为1.41万亿元，同比下降10.6%，归母净利润为214.83亿元，同 比下降39.8%。 宝丰能源：上半年归母净利润同比增长73.02% 宝丰能源公告，2025年上半年营业收入为228.20亿元，同比增长35.05%，归母净利润为57.18亿元，同 比增长73.02%。 增减持 中银证券：江西铜业拟减持不超公司3%的股份 中银证券公告，截至公告披露日，股东江西铜业持有公司1.3亿股，占公司总股本的4.70%；因自身经营 发展需要，拟合计减持不超过8334万股，即不超公 ...

Macro Dynamics - The Ministry of Commerce reported that rural online retail sales increased by 6.4% year-on-year from January to July 2025, with agricultural product online retail sales growing by 7.4% during the same period [2] - The National Energy Administration announced that the total electricity consumption in July 2025 reached 10,226 billion kWh, a year-on-year increase of 8.6% [3] - The National Development and Reform Commission plans to conduct central frozen pork reserve storage to stabilize the pig market due to a slight decline in pork prices [4][5] Industry Developments - Anhui Province is accelerating the establishment of a provincial artificial intelligence industry fund with a total scale of no less than 20 billion yuan to support the AI sector [6] - The China Index Academy reported that 20 distressed real estate companies have restructured debts exceeding 12 billion yuan as of August 2025 [7] Financial Institutions - The Shenzhen Financial Regulatory Bureau revealed that 403 "white list" projects have been approved by banks in the region, with a total approved amount of 549.3 billion yuan [7] Company News - China Petroleum & Chemical Corporation (Sinopec) reported a 39.8% year-on-year decline in net profit for the first half of 2025, with revenue of 1.41 trillion yuan, down 10.6% [14] - Jishi Media announced a net loss of 232 million yuan for the first half of 2025, despite a revenue increase of 8.7% to 997 million yuan [15] - Bilibili reported a second-quarter revenue of 7.34 billion yuan, a 20% year-on-year increase, and a non-GAAP net profit of 560 million yuan, reversing a loss from the previous year [16] - Xian Dao Intelligent stated that it has achieved significant breakthroughs in solid-state battery production and has received repeat orders from leading domestic and international companies [17] - Vivo launched its first MR headset, the Vivo Vision Exploration Edition, which is not intended for consumer sales at this time [18]

Company Announcements - Dameng Data's board member and senior vice president is under investigation by the Hubei Provincial Supervisory Committee, but the company's operations remain normal [1] - Jishi Media reported a net loss of 232 million yuan in the first half of 2025, despite a revenue increase of 8.7% to 999.7 million yuan [2] - Wantai Biological's nine-valent HPV vaccine has received its first batch release certificate, marking its market entry and potential revenue growth [2] - Feilu Co., Ltd. is undergoing a change in control, leading to a suspension of its stock trading starting August 22 [2] Financial Performance - Sany Heavy Industry reported a 46% increase in net profit to 5.216 billion yuan in the first half of 2025, with a revenue of 44.534 billion yuan, up 14.96% [3] - EVE Energy's net profit decreased by 24.9% to 1.605 billion yuan, despite a revenue increase of 30.06% to 28.169 billion yuan [5] - GoerTek achieved a net profit increase of 15.65% to 1.42 billion yuan, with a revenue of 37.55 billion yuan, down 7.02% [6] Approvals and Projects - Changchun High-tech's subsidiary received acceptance for a clinical trial application for GenSci143, a dual-specificity antibody drug targeting B7-H3 and PSMA [7] - Zejing Pharmaceutical received approval for clinical trials of ZG005 and ZGGS18 in combination with a specific cancer drug [7] Financing and Capital Increase - Zhenghe Industrial plans to raise no more than 818 million yuan through a private placement for various projects and working capital [8] Shareholding Changes - Zhongyin Securities announced that Jiangxi Copper plans to reduce its stake by up to 3%, equating to 83.34 million shares [9] - Mengke Pharmaceutical's shareholders plan to transfer 22.946 million shares, representing 3.5% of the total share capital [15] Investments and Strategic Partnerships - Diou Home plans to establish a wholly-owned subsidiary with an investment of 500 million yuan to expand into the generative AI field [11] - Gree Green signed a strategic cooperation agreement with Weilan Lithium to develop ultra-high energy density battery materials and solid-state battery innovations [12]

Group 1: Company Performance - Sinopec reported a revenue of 1.4 trillion yuan and a net profit of 23.75 billion yuan for the first half of 2025, with a cash dividend of 0.088 yuan per share, representing a payout ratio of 49.7% [1] - GoerTek achieved a net profit of 1.42 billion yuan, marking a year-on-year increase of 15.65%, despite a revenue decline of 7.02% to 37.55 billion yuan [2] - Gree Electric announced a cash dividend of 20 yuan per 10 shares, totaling 11.17 billion yuan, based on a share base of 5.585 billion shares [3] - Jishi Media reported a revenue of 999.7 million yuan, with a net loss of 232 million yuan for the first half of 2025 [4] - Changchun High-tech's subsidiary received approval for a clinical trial of a dual-specific antibody drug, GenSci143, targeting B7-H3 and PSMA [5] - Greenme announced a strategic partnership with Weilan Lithium to develop high-energy battery materials and solid-state battery technologies [6] Group 2: Share Buybacks and Reductions - Sinopec plans to repurchase shares worth between 5 billion and 10 billion yuan through the Shanghai Stock Exchange [26] - Jiangxi Copper intends to reduce its stake in Zhongyin Securities by up to 3%, equating to 83.34 million shares [7] - Hengbang Mining plans to reduce its stake in the Hong Kong-listed company, WanGuo Gold, by up to 3.69% of its total share capital [10] Group 3: New Product Developments - Renhe Pharmaceutical's subsidiary is developing a brain-machine interaction smart glasses product, which is currently in the testing phase and has not yet generated sales revenue [11] - TianTan Bio received a commitment from its controlling shareholders to resolve new competition issues arising from a recent acquisition [12] - XianDao Intelligent has successfully developed a mass production solution for solid-state batteries and received repeat orders for related products [13] - Zejing Pharmaceutical received approval for clinical trials of ZG005 and ZGGS18 in combination with a cancer treatment drug [14] - Wantai Bio received a production approval for its nine-valent HPV vaccine, marking a new revenue stream [15]

Group 1 - The core point of the article is that Jiangxi Copper Company plans to reduce its holdings in Zhongyin Securities by up to 83.34 million shares, which is no more than 3% of Zhongyin Securities' total share capital [1] - As of the announcement date, Jiangxi Copper holds 130 million unrestricted circulating shares of Zhongyin Securities, accounting for 4.7% of the total share capital [1]